Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Neuroimaging in human MDMA (Ecstasy) users.

Cowan RL, Roberts DM, Joers JM.

Ann N Y Acad Sci. 2008 Oct;1139:291-8. doi: 10.1196/annals.1432.007.

2.

Neuroimaging research in human MDMA users: a review.

Cowan RL.

Psychopharmacology (Berl). 2007 Jan;189(4):539-56. Epub 2006 Jul 18. Review.

PMID:
16847678
3.

Toxicodynamics and long-term toxicity of the recreational drug, 3, 4-methylenedioxymethamphetamine (MDMA, 'Ecstasy').

Ricaurte GA, McCann UD, Szabo Z, Scheffel U.

Toxicol Lett. 2000 Mar 15;112-113:143-6. Review.

PMID:
10720723
4.

(+/-)3,4-Methylenedioxymethamphetamine ('Ecstasy')-induced serotonin neurotoxicity: studies in animals.

Ricaurte GA, Yuan J, McCann UD.

Neuropsychobiology. 2000;42(1):5-10. Review.

PMID:
10867550
5.

Evidence for chronically altered serotonin function in the cerebral cortex of female 3,4-methylenedioxymethamphetamine polydrug users.

Di Iorio CR, Watkins TJ, Dietrich MS, Cao A, Blackford JU, Rogers B, Ansari MS, Baldwin RM, Li R, Kessler RM, Salomon RM, Benningfield M, Cowan RL.

Arch Gen Psychiatry. 2012 Apr;69(4):399-409. doi: 10.1001/archgenpsychiatry.2011.156. Epub 2011 Dec 5.

8.

A PET study of effects of chronic 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") on serotonin markers in Göttingen minipig brain.

Cumming P, Møller M, Benda K, Minuzzi L, Jakobsen S, Jensen SB, Pakkenberg B, Stark AK, Gramsbergen JB, Andreasen MF, Olsen AK.

Synapse. 2007 Jul;61(7):478-87.

PMID:
17415793
9.

Positron emission tomographic evidence of toxic effect of MDMA ("Ecstasy") on brain serotonin neurons in human beings.

McCann UD, Szabo Z, Scheffel U, Dannals RF, Ricaurte GA.

Lancet. 1998 Oct 31;352(9138):1433-7.

PMID:
9807990
10.
11.

Neuroimaging findings with MDMA/ecstasy: technical aspects, conceptual issues and future prospects.

Reneman L, de Win MM, van den Brink W, Booij J, den Heeten GJ.

J Psychopharmacol. 2006 Mar;20(2):164-75. Review.

PMID:
16510475
12.
14.

Sustained recreational use of ecstasy is associated with altered pre and postsynaptic markers of serotonin transmission in neocortical areas: a PET study with [¹¹C]DASB and [¹¹C]MDL 100907.

Urban NB, Girgis RR, Talbot PS, Kegeles LS, Xu X, Frankle WG, Hart CL, Slifstein M, Abi-Dargham A, Laruelle M.

Neuropsychopharmacology. 2012 May;37(6):1465-73. doi: 10.1038/npp.2011.332. Epub 2012 Feb 22.

16.

MDMA-induced c-Fos expression in oxytocin-containing neurons is blocked by pretreatment with the 5-HT-1A receptor antagonist WAY 100635.

Hunt GE, McGregor IS, Cornish JL, Callaghan PD.

Brain Res Bull. 2011 Aug 10;86(1-2):65-73. doi: 10.1016/j.brainresbull.2011.06.011. Epub 2011 Jul 1.

PMID:
21745546
17.

Ecstasy induces apoptosis via 5-HT(2A)-receptor stimulation in cortical neurons.

Capela JP, Fernandes E, Remião F, Bastos ML, Meisel A, Carvalho F.

Neurotoxicology. 2007 Jul;28(4):868-75. Epub 2007 Apr 27.

PMID:
17572501
18.

Human Ecstasy use is associated with increased cortical excitability: an fMRI study.

Bauernfeind AL, Dietrich MS, Blackford JU, Charboneau EJ, Lillevig JG, Cannistraci CJ, Woodward ND, Cao A, Watkins T, Di Iorio CR, Cascio C, Salomon RM, Cowan RL.

Neuropsychopharmacology. 2011 May;36(6):1127-41. doi: 10.1038/npp.2010.244. Epub 2011 Feb 16.

19.

Development and characterization of a novel animal model of intermittent MDMA ("Ecstasy") exposure during adolescence.

Meyer JS, Piper BJ, Vancollie VE.

Ann N Y Acad Sci. 2008 Oct;1139:151-63. doi: 10.1196/annals.1432.029.

PMID:
18991859
20.

Supplemental Content

Support Center